Improving Care

Reducing morbidity and mortality and enhancing quality of life

Informing Policy

Transforming health care at the local, national and international levels

Featured Projects

With more than 80 scientists, research at Advancing Health encompasses a wide breadth of areas

COVID-19

The Evidence Speaks

A recurring feature highlighting the latest in Advancing Health research

Our People

In the News

Research Resources

From design to execution, Advancing Health provides a broad range of support services

Work in Progress Seminar Series

Publications

The work of our scientists, research associates, and staff are often found in the pages of top journals. Each year, our researchers publish over 400 peer-reviewed papers.


  • Gill JS. Is dialysis modality a factor in the survival of patients initiating dialysis after kidney transplant failure?

    February 27, 2015

    Perl J, Dong J, Rose C, Jassal SV, Gill JS. Is dialysis modality a factor in the survival of patients initiating dialysis after kidney transplant failure? Perit Dial Int. 2013 Nov-Dec;33(6):618-28. doi: 10.3747/pdi.2012.00280. Epub 2013 Oct 1. PMID: 24084843.

    Read More

  • Gill JS. Understanding rare adverse outcomes following living kidney donation. Comment on Risk of end-stage renal disease following live kidney donation.

    February 25, 2015

    Gill JS, Tonelli M. Understanding rare adverse outcomes following living kidney donation. Comment on Risk of end-stage renal disease following live kidney donation. JAMA. 2014 Feb 12;311(6):577-9. doi: 10.1001/jama.2013.285142. PMID: 24519296.

    Read More

  • Ayas N. Carotid intima media thickness in patients with obstructive sleep apnea: Comparison with a community-based cohort.

    February 25, 2015

    Fox N, Ayas N, Park JE, Fleetham J, Frank Ryan C, Lear SA, Mulgrew A, Chan S, Hill J, John Mancini GB, Wong GC. Carotid intima media thickness in patients with obstructive sleep apnea: Comparison with a community-based cohort. Lung. 2014 Apr; 192(2):297–303. Epub 2014 Jan 29. PMID: 24469113.

    Read More

  • Koehoorn M. Weighty problems: Sport injuries in overweight or obese active Canadian adolescents.

    February 25, 2015

    Ezzat A, Schneeberg A, Koehoorn M. Weighty problems: Sport injuries in overweight or obese active Canadian adolescents. Br J Sports Med. 2014 Apr;48(7): 592.

    Read More

  • Dodek PM, Wong H. Assessing the influence of intensive care unit organizational factors on outcomes in Canada: Is there residual confounding?

    February 25, 2015

    Dodek PM, Norena M, Wong H, Keenan S, Martin C. Assessing the influence of intensive care unit organizational factors on outcomes in Canada: Is there residual confounding? J Intensive Care Med. 2014 Feb 7. Epub ahead of print. PMID: 24509494.

    Read More

  • Grafstein E. Modelling clinical progression and health care utilization of HIV-positive patients in British Columbia prior to death.

    February 25, 2015

    Cui Z, Grafstein E, Yip B, Hogg R, Montaner J, Lima V. Modelling clinical progression and health care utilization of HIV-positive patients in British Columbia prior to death. HIV Med. 2014 Oct;15(9):557-64. doi: 10.1111/hiv.12151. Epub 2014 Mar 18. PMID: 24641495.

    Read More

  • Wong H, Singer J. The relationship between subchondral sclerosis detected with MRI and cartilage loss in a cohort of subjects with knee pain: The Knee Osteoarthritis Progression (KOAP) study.

    February 25, 2015

    Crema MD, Cibere J, Sayre EC, Roemer FW, Wong H, Thorne A, Singer J, Esdaile JM, Marra MD, Kopec JA, Nicolaou S, Guermazi A. The relationship between subchondral sclerosis detected with MRI and cartilage loss in a cohort of subjects with knee pain: The Knee Osteoarthritis Progression (KOAP) study. Osteoarthritis Cartilage. 2014 Apr;22(4):540-6. doi: 10.1016/j.joca.2014.01.006. Epub 2014 Feb 6.  PMID: 24508776.

    Read More

  • Dodek P. Barriers and facilitators of thromboprophylaxis for medical-surgical intensive care unit patients: A multicenter survey.

    February 25, 2015

    Cook D, Duffett M, Lauzier F, Ye C, Dodek P, Paunovic B, Fowler R, Kho ME, Foster D, Stelfox T, Sinuff T, Zytaruk N, Clarke F, Wood G, Cox M, Kutsiogiannis J, Jacka M, Roussos M, Kumar H, Guyatt G; for the CONECCKT-T (Co-operative Network of Critical Care Knowledge Translation for Thromboprophylaxis) Investigators and the Canadian Critical Care Trials Group. Barriers and facilitators of thromboprophylaxis for medical-surgical intensive care unit patients: A multicenter survey. J Crit Care. 2014 Jun;29(3):471.e1-9. doi: 10.1016/j.jcrc.2014.01.017. Epub 2014 Feb 5. PMID: 24629574.

    Read More

  • Humphries KH. Prevalence and control of high blood pressure in primary care—results from the German metabolic and cardiovascular risk study (GEMCAS).

    February 25, 2015

    Balijepalli C, Bramlage P, Losch C, Zemmrich C, Humphries KH, Moebus S. Prevalence and control of high blood pressure in primary care—results from the German metabolic and cardiovascular risk study (GEMCAS). Hypertens Res. 2014 Jun;37(6):580-4. doi: 10.1038/hr.2014.40. Epub 2014 Mar 13. PMID: 24621471.

    Read More

  • Cundiff G. A biomechanics model to assess the contribution of pelvic musculature weakness to the development of stress urinary incontinence.

    February 26, 2015

    Yip C, Kwok E, Sassani F, Jackson R, Cundiff G. A biomechanics model to assess the contribution of pelvic musculature weakness to the development of stress urinary incontinence. Comput Methods Biomech Biomed Engin. 2014 Feb; 17(2):163–76. Epub 2012 Apr 11. PMID: 22494663.

    Read More

  • Werker GR, Bansback N, Anis AH. Optimal timing of influenza vaccination in patients with human immunodeficiency virus: A Markov cohort model based on serial study participant hemoagglutination inhibition titers.

    February 26, 2015

    Werker GR, Sharif B, Sun H, Cooper C, Bansback N, Anis AH. Optimal timing of influenza vaccination in patients with human immunodeficiency virus: A Markov cohort model based on serial study participant hemoagglutination inhibition titers. Vaccine. 2014 Feb 3;32(6):677-84. doi: 10.1016/j.vaccine.2013.11.103. Epub 2013 Dec 16. PMID 24355089.

    Read More

  • Shojania K. Cost-effectiveness of abatacept for moderate-to-severe rheumatoid arthritis.

    February 26, 2015

    Tsao NW, Shojania K, Marra CA. Cost-effectiveness of abatacept for moderate-to-severe rheumatoid arthritis. Expert Rev Pharmacoecon Outcomes Res. 2014 Feb; 14(1):9–18. Epub 2013 Dec 10. PMID: 24325566.

    Read More